Indian pharma companies turn bullish on M&A route https://ift.tt/tzj948y

The industry saw 16 deals during 2022, the largest perhaps in a decade, worth nearly a billion dollars in value. Interestingly, it’s not foreign companies that have backed these acquisitions. It’s the local firms that have become aggressive acquirers, snapping up brands of even MNCs.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/PeDxJjA